Rubicon Research Private Limited: Drug Recall
Recall #D-0517-2024 · 05/06/2024
Class II: Risk
Recall Details
- Recall Number
- D-0517-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Rubicon Research Private Limited
- Status
- Ongoing
- Date Initiated
- 05/06/2024
- Location
- Ambarnath, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,664 Bottles
Reason for Recall
Presence of Foreign Substance: metal in tablet
Product Description
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00
Distribution Pattern
Nationwide
Other Recalls by Rubicon Research Private Limited
- Class III: Low Risk 08/24/2024
- Class II: Risk 04/26/2024
- Class II: Risk 12/31/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.